SENS stock news · Senseonics
Get alerts for SENS
Follow Senseonics (SENS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SENSFree on the App Store and Google Play, or on the web.
Beta Bionics has started using its iLet system with the Eversense 365 glucose monitor to help diabetes patients.
Good for SENSSenseonics' Eversense 365 is now part of Beta Bionics' launched iLet system, where its readings help automate insulin decisions. The story gives no sales or patient-use figures, but the launch gives the sensor a new commercial use.
Senseonics and Beta Bionics are launching the Eversense 365 system to help manage diabetes better.
Good for SENSSenseonics launched its year-long glucose monitor with Beta Bionics' insulin system, meeting their fourth-quarter 2026 target. This puts its sensor in a combined product and supports Senseonics.
Senseonics Holdings shares the full details of its earnings call for the second quarter of 2026.
Good for SENSSenseonics reported about 120% second-quarter sales growth, raised its 2026 sales and gross margin targets, and raised over $100 million. The update points to stronger business prospects.